Company Filing History:
Years Active: 2019-2025
Title: Raquel Orozco: Pioneering Innovations in Viral Inactivation
Introduction
Raquel Orozco, an accomplished inventor based in El Cerrito, California, has made significant contributions to the field of viral inactivation with a total of seven patents to her name. Her work focuses on developing methods that enhance the safety and efficiency of protein manufacture by effectively inactivating viruses.
Latest Patents
Orozco's latest patents include innovative methods for continuously inactivating a virus during the manufacture of proteins. These methodologies involve combining a protein composition with a virus-inactivation reagent at a predetermined volumetric ratio to create a treatment composition. This process allows for the maintenance of specific properties across a range of protein concentrations, without requiring feedback control. Additionally, she has developed a system to determine critical process parameters for a continuous viral inactivation reactor, showcasing her commitment to advancing the technology in this vital area.
Career Highlights
Raquel Orozco is currently affiliated with Boehringer Ingelheim International GmbH, where she continues to drive innovations in viral inactivation technologies. Her expertise in process design and her ability to create effective solutions for complex challenges in protein manufacture have established her as a respected figure in her field.
Collaborations
During her career, Orozco has collaborated with notable colleagues, including Jonathan Coffman and Marcus Andre Fiadeiro. This collaborative spirit has been pivotal in fostering an environment of innovation and enhanced research output within her team.
Conclusion
Raquel Orozco stands out as an influential inventor whose work has considerably impacted viral inactivation processes in protein manufacture. With her extensive patent portfolio and dedication to innovation, she continues to pave the way for safer biological manufacturing practices.